Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 398K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 20K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 21K
12: R1 Document and Entity Information HTML 42K
13: R2 Consolidated Balance Sheets HTML 130K
14: R3 Consolidated Balance Sheets (Parenthetical) HTML 44K
15: R4 Consolidated Statements of Operations (Unaudited) HTML 86K
16: R5 Consolidated Statements of Comprehensive Income HTML 45K
(Loss) (Unaudited)
17: R6 Consolidated Statements of Cash Flows (Unaudited) HTML 114K
18: R7 Consolidated Statements of Cash Flows HTML 23K
(Parenthetical) (Unaudited)
19: R8 Basis of Presentation HTML 26K
20: R9 IDT Financial Services Holding Limited Assets and HTML 50K
Liabilities Held for Sale
21: R10 Spin-Off of Rafael Holdings, Inc. and Investment HTML 41K
in Rafael Pharmaceuticals, Inc.
22: R11 Marketable Securities HTML 67K
23: R12 Fair Value Measurements HTML 59K
24: R13 Equity HTML 44K
25: R14 Earnings (Loss) Per Share HTML 45K
26: R15 Revolving Credit Facility HTML 24K
27: R16 Accumulated Other Comprehensive Loss HTML 32K
28: R17 Business Segment Information HTML 46K
29: R18 Commitments and Contingencies HTML 53K
30: R19 Other Income (Expense), Net HTML 32K
31: R20 Income Tax and New Jersey Corporation Business Tax HTML 39K
32: R21 Recently Issued Accounting Standard Not Yet HTML 40K
Adopted
33: R22 IDT Financial Services Holding Limited Assets and HTML 46K
Liabilities Held for Sale (Tables)
34: R23 Proposed Spin-Off of Rafael Holdings, Inc. and HTML 26K
Investment in Rafael Pharmaceuticals, Inc.
(Tables)
35: R24 Marketable Securities (Tables) HTML 66K
36: R25 Fair Value Measurements (Tables) HTML 48K
37: R26 Equity (Tables) HTML 31K
38: R27 Earnings (Loss) Per Share (Tables) HTML 43K
39: R28 Accumulated Other Comprehensive Loss (Tables) HTML 30K
40: R29 Business Segment Information (Tables) HTML 39K
41: R30 Other Income (Expense), Net (Tables) HTML 30K
42: R31 IDT Financial Services Holding Limited Assets and HTML 91K
Liabilities Held for Sale (Details)
43: R32 IDT Financial Services Holding Limited Assets and HTML 29K
Liabilities Held for Sale (Details 1)
44: R33 IDT Financial Services Holding Limited Assets and HTML 30K
Liabilities Held for Sale (Details Textual)
45: R34 Spin-Off of Rafael Holdings, Inc. and Investment HTML 29K
in Rafael Pharmaceuticals, Inc. (Details)
46: R35 Spin-Off of Rafael Holdings, Inc. and Investment HTML 87K
in Rafael Pharmaceuticals, Inc. (Details Textual)
47: R36 Marketable Securities (Details) HTML 69K
48: R37 Marketable Securities (Details 1) HTML 35K
49: R38 Marketable Securities (Details 2) HTML 44K
50: R39 Marketable Securities (Details 3) HTML 30K
51: R40 Marketable Securities (Details Textual) HTML 39K
52: R41 Fair Value Measurements (Details) HTML 38K
53: R42 Fair Value Measurements (Details 1) HTML 28K
54: R43 Fair Value Measurements (Details Textual) HTML 23K
55: R44 Equity (Details) HTML 62K
56: R45 Equity (Details Textual) HTML 64K
57: R46 Earnings (Loss) Per Share (Details) HTML 33K
58: R47 Earnings (Loss) Per Share (Details 1) HTML 28K
59: R48 Revolving Credit Facility (Details) HTML 41K
60: R49 Accumulated Other Comprehensive Loss (Details) HTML 49K
61: R50 Accumulated Other Comprehensive Loss (Details HTML 29K
Textual)
62: R51 Business Segment Information (Details) HTML 45K
63: R52 Business Segment Information (Details Textual) HTML 21K
64: R53 Commitments and Contingencies (Details) HTML 48K
65: R54 Other Income (Expense), Net (Details) HTML 35K
66: R55 Income Tax and New Jersey Corporation Business Tax HTML 47K
(Details)
68: XML IDEA XML File -- Filing Summary XML 123K
67: EXCEL IDEA Workbook of Financial Reports XLSX 71K
6: EX-101.INS XBRL Instance -- idt-20180131 XML 1.17M
8: EX-101.CAL XBRL Calculations -- idt-20180131_cal XML 144K
9: EX-101.DEF XBRL Definitions -- idt-20180131_def XML 523K
10: EX-101.LAB XBRL Labels -- idt-20180131_lab XML 1.10M
11: EX-101.PRE XBRL Presentations -- idt-20180131_pre XML 739K
7: EX-101.SCH XBRL Schema -- idt-20180131 XSD 145K
69: ZIP XBRL Zipped Folder -- 0001213900-18-002826-xbrl Zip 122K
Filing Submission 0001213900-18-002826 – SGML Text
To view the SGML, please refresh this page.
↑Top
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Tue., Apr. 30, 7:07:31.1pm ET